This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Apple, DuPont: New Targets, Estimates

Also see: ADP, Amdocs, Cree: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Apple (AAPL - Get Report) estimates were increased through 2012 at Needham. Company should see better iPad and Mac shipments, Needham said. Maintain $450 price target.

Cytec (CYT - Get Report) estimates, target were cut through 2012 at Jefferies. Company could face further weakness in its coatings business, Jefferies said. Buy rating and new $64 price target.

DuPont (DD - Get Report) estimates were increased at Jefferies through 2012. Company is realizing higher TiO2 prices, Jefferies said. Buy rating and $64 price target.

Forest Laboratories (FRX) estimates, target were increased at Credit Suisse. Shares now seen reaching $46, and estimates were also increased on M&A interest by larger peers. Credit Suisse said.

Garmin (GRMN - Get Report) estimates, target were lowered at Goldman Sachs. Shares now seen reaching $30. Estimates also cut, following the warning from TomTom, Goldman said. Neutral rating.

Grainger (GWW) estimates, target were raised at UBS. Shares now seen reaching $156. Estimates also increased on good opportunities on margins, UBS said. Neutral rating.

Huntsman (HUN) estimates, target were raised at Jefferies. Shares now seen reaching $26. Estimates also increased, given higher TiO2 prices, Jefferies said. Buy rating.

Johnson Controls (JCI) estimates, target were increased at Piper Jaffray. Shares now seen reaching $51. Estimates were also increased on stronger-than-expected start-stop battery demand, Piper Jaffray said. Overweight rating.

Jacobs Engineering (JEC) estimates, target cut at UBS. Shares now seen reaching $45. Estimates also lowered, as macro pressures remain UBS said. Neutral rating.

Marathon Oil (MRO - Get Report) estimates were boosted through 2013 at UBS. Improved refining margin outlook, UBS said. Maintain Buy rating and $60 price target.

Teva Pharmaceutical (TEVA - Get Report) estimates were lowered through 2012 at Jefferies. Stock is down 16% over the past year, even though the company has made positive strategic moves, Jefferies said. Hold rating and $53 price target.

End of report.

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
FRX $99.00 -0.77%
AAPL $130.28 0.00%
CYT $60.49 0.00%
DD $71.01 0.00%
GRMN $45.48 0.00%

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs